Jeil-Kirin Pharmaceutical Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Jeil-Kirin Pharmaceutical Inc.
Deal Watch: Valeant Continues Divestment Spree By Selling Obagi At A Loss
Emergent reveals acquisition of GSK's anthrax therapy raxibacumab days after a vaccine deal with Sanofi. Telix licenses PSMA antibodies from Abzena, while PeptiDream and Kleo sign an immuno-oncology pact.
Company Information
- Industry
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice